A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trialChristoph Röllig, H. Bodenstein, Martin Bornhäuser et al.|Blood|2010Cited by 177
Cytarabine Dose of 36 g/m<sup>2</sup> Compared With 12 g/m<sup>2</sup> Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 StudyMarkus Schaich, Gerhard Ehninger, Christoph Röllig et al.|Journal of Clinical Oncology|2011Cited by 102
Cup-like acute myeloid leukemia: new disease or artificial phenomenon?Frank Kroschinsky, Ulrike Schäkel, Rainer Fischer et al.|Haematologica|2008Cited by 45